Search research articles
Contact Us
Filters
Showing results (161-170 of 246) with videos related to
Page
of 25
Sort By:
The Oncologist
|
April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC
Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
European Urology Focus
|
September 22, 2024
Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma
Emily Wang, Eric S Rupe, Sagar S Mukhida, et al.
JCO Oncology Practice
|
September 21, 2020
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
Cristiane Decat Bergerot, Dena Battle, Errol J Philip, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
European Urology Oncology
|
July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients
Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Urologic Oncology
|
July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma
Daniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
British Journal of Cancer
|
August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study
Troy J Kleber, Alexander D Sherry, Andrew J Arifin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 246) with videos related to
Sort By:
Page
of 25
The Oncologist
|
April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC
Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
European Urology Focus
|
September 22, 2024
Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma
Emily Wang, Eric S Rupe, Sagar S Mukhida, et al.
JCO Oncology Practice
|
September 21, 2020
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
Cristiane Decat Bergerot, Dena Battle, Errol J Philip, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
European Urology Oncology
|
July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients
Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Urologic Oncology
|
July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma
Daniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
British Journal of Cancer
|
August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study
Troy J Kleber, Alexander D Sherry, Andrew J Arifin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Page
of 25